Stock Track | Senseonics Soars 5.07% Intraday on Acquisition of Eversense U.S. Assets from Ascensia

Stock Track
01/03

Senseonics Holdings Inc. (SENS) saw its stock surge 5.07% during intraday trading on Friday, reflecting strong investor optimism following the company's strategic acquisition announcement.

The medical technology company entered into a Master Asset Purchase Agreement with Ascensia Diabetes Care Holdings AG to acquire U.S. assets related to the marketing, selling, and distribution of the Eversense® continuous glucose monitoring (CGM) system. The deal, which closed on January 1, 2026, also includes plans for Senseonics to expand its footprint in Europe by acquiring additional Eversense-related assets in Italy, Germany, Spain, and Sweden by mid-2026, pending regulatory approvals.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10